Related Experiment Video
Updated: Jun 13, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Diabetes and cardiovascular outcomes: finding the silver lining.
L Chen1, Y T Shen, R P Shannon
1Cardiovascular Institute and the Department of Medicine, University of Pennsylvania, School of Medicine, Philadelphia, PA, USA.
Minerva Cardioangiologica
|May 5, 2010
Summary
Type 2 diabetes and cardiovascular disease pose significant public health risks. Current treatments focusing solely on tight glycemic control show disappointing cardiovascular outcomes, necessitating new therapeutic strategies.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) exhibit a dangerous synergy, impacting global public health.
- Hyperglycemia in T2DM is linked to cardiomyocyte and endothelial cell toxicity, yet intensive glycemic control trials have yielded disappointing cardiovascular outcome results.
Purpose of the Study:
- To review the epidemiological and mechanistic links between diabetes and adverse cardiovascular outcomes.
- To analyze recent clinical trial data regarding glycemic control and cardiovascular outcomes.
- To propose novel therapeutic approaches for T2DM that include glycemic control and cardio-protective mechanisms.
Main Methods:
- Literature review of epidemiological studies on diabetes and CVD.
- Examination of mechanistic evidence for hyperglycemia-induced cellular damage.
- Analysis of data from recent clinical trials on glycemic control and cardiovascular outcomes.
- Discussion of emerging therapeutic strategies beyond conventional glycemic control.
Main Results:
- Despite strong evidence, tight glycemic control alone has not consistently improved cardiovascular outcomes in T2DM patients.
- Mechanistic studies support hyperglycemia's role in cardiovascular cellular damage.
- Recent trials highlight the limitations of solely focusing on glycemic targets.
Conclusions:
- The paradox of hyperglycemia's toxicity versus disappointing clinical trial results necessitates a re-evaluation of therapeutic strategies.
- New approaches should integrate glycemic control with mechanisms offering direct cardio-protection.
- Future therapies may offer improved cardiovascular outcomes with reduced side effects in T2DM management.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...